Innovative Diagnostic Technology Brainreader's Neuroreader® software offers advanced, FDA-cleared brain volumetric analysis, enabling detection of subtle brain changes that can aid in early diagnosis and personalized treatment planning, making it highly attractive to neurology and radiology clinics seeking cutting-edge tools.

Strong Growth & Funding With recent financing of over $7.5 million and strategic partnerships, Brainreader is expanding its AI-driven neuroimaging platform, presenting opportunities for sales growth among medical centers investing in innovative diagnostic solutions and technological upgrades.

Expanding Market Presence Recent hires of key U.S. sales leadership and partnerships with prominent imaging companies indicate a focus on increasing market penetration in North America, offering a route for targeted outreach to hospitals and imaging providers seeking advanced neuroimaging analytics.

Strategic Collaborations Partnerships with Phenomehealth, Blackford Analysis, and INFINITT North America demonstrate Brainreader’s commitment to integrating with leading healthcare platforms, creating cross-selling opportunities with existing clients and potential clients using these systems.

Targeted Customer Base Operating in the medical equipment sector with a focus on neuroimaging, Brainreader's primary customers are likely neuro-specialists, academic research institutions, and hospitals investing in early detection and brain health research, offering tailored sales approaches for these segments.